| Cas No.: | 956104-40-8 |
| 名称: | Benzamide,4-[7-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oct-5-yl]-2-fluoro-N-methyl- |
| 别名: | ARN 509; ARN-509 |
| SMILES: | CNC(=O)C1=C(C=C(C=C1)N2C(=S)N(C(=O)C23CCC3)C4=CN=C(C(=C4)C(F)(F)F)C#N)F |
| 分子式: | C21H15F4N5O2S |
| 分子量: | 477.43 |
| 纯度: | |
| 保存条件: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | |
| In Vivo: | |
| In Vitro: | |
| References: | ARN-509 (< 10 μM) inhibits androgen-mediated induction or repression of mRNA expression levels For 13 endogenous genes including PSA and TMPRSS2 in the LNCaP/AR prostate cancer cell line. ARN-509 (< 10 μM) inhibits the proliferative effect of R1881 (30 p |
| Kinase Assay: | |
| Cell Assay: | |
| Animal Administration: | |
| References: |




